Monsanto plots pricey Syngenta comeback amid growing scepticism

LONDON/FRANKFURT (Reuters) – U.S. agrochemicals firm Monsanto Co and its advisers are working flat out to accommodate Syngenta’s qualms about regulatory hurdles to a deal whose perils may well outweigh the rewards.

Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

20 − 6 =